About Clearbridge BioMedics
Clearbridge BioMedics is a clinical stage cancer diagnostics company that develops and manufactures liquid biopsy systems. The Company is based in Singapore and has commercially launched the ClearCell® FX platform sales to clinical research centers around the globe. The Company has won numerous awards and garnered global recognition for its novel Circulating Tumor Cell (CTC) detection platform technology, the ClearCell® FX System. CBB received ISO 13485 certification in 2011 and the ClearCell® FX attained CE IVD in 2015.
ClearCell® FX System and its biochip are utilizing state-of-the-art, non-invasive liquid biopsy to analyze blood samples for circulating tumor cells (CTCs), the device allows for real time analysis of disease before, during, and after treatment, which has become increasingly critical in the new era of targeted cancer therapies.